Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Rybak, Michael J; Le, Jennifer; Lodise, Thomas P; Levine, Donald P; Bradley, John S; Liu, Catherine; Mueller, Bruce A; Pai, Manjunath P; Wong-Beringer, Annie; Rotschafer, John C; Rodvold, Keith A; Maples, Holly D; Lomaestro, Ben

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Issue Date

5/19/2020

Authors

Rybak, Michael J

Le, Jennifer

Lodise, Thomas P

Levine, Donald P

Bradley, John S

Liu, Catherine

Mueller, Bruce A

Pai, Manjunath P

Wong-Beringer, Annie

Rotschafer, John C

Show 3 more

Citation

Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036. PMID: 32191793.